Maze Therapeutics, Inc.

Direct answer

Maze Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MAZE.

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule...

Can you invest in Maze Therapeutics, Inc.?

Yes. Maze Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MAZE.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Maze Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.